Latest News

PharmAust enters monepantel agreement with Elanco April 19, 2018

PharmAust (ASX:PAA), a clinical-stage oncology company, has announced it has entered into an option agreement with Elanco US to develop monepantel as a novel therapy to treat cancer in dogs.

Applications open for new round of sector growth program April 19, 2018

The program offers up to $1 million to support projects focused on creating jobs, as well as driving growth, the productivity and competitiveness of local businesses.

Pharmaceutical leader joins QEDDI advisory committee April 19, 2018

International drug-discovery leader Dr Jeanette Wood has been appointed to the advisory committee of The University of Queensland’s (UQ) drug discovery initiative, QEDDI, the Queensland Emory Drug Discovery Initiative.

Industry welcomes first grants under BioMedTech Horizons program April 19, 2018

The Turnbull government has announced the first 11 recipients of the $35 million BioMedTech Horizons program.

CSL Behring commits on World Haemophilia Day April 17, 2018

CSL Behring has marked World Haemophilia Day by shipping more than 10 million units of its medicines to treat Haemophilia A to the World Federation for Haemophilia Global Alliance for Progress Program.

Amgen joins Digital Health CRC April 17, 2018

Amgen has become the only pharmaceutical industry member of the new Digital Health CRC consortium.

Leadership of AusMedtech National Advisory Group to change April 17, 2018

AusBiotech acknowledges the substantial contribution of Warren Bingham as Chair of the AusMedtech National Advisory Group as he steps down after extended service and welcomes newly-appointed Chair, Mr David Cain.

Telix signs partnership with French nuclear medicine researchers April 17, 2018

Telix Pharmaceuticals (ASX.TLX) has announced a research partnership with the French National Institute of Health and Medical Research and the Accelerator for Research in Radiochemistry and Oncology at Nantes Atlantic.

Avita reports positive RECELL trial result April 17, 2018

AVITA Medical (ASX:AVH) says its pivotal trial in the treatment of third-degree burns with the RECELL Autologous Cell Harvesting Device achieved its co-primary endpoints.

Bionomics progresses PTSD trial April 12, 2018

Adelaide-based Bionomics (ASX:BNO) has announced that the RESTORE trial, a phase 2 clinical trial designed to evaluate the safety and efficacy of BNC210 for the treatment of post-traumatic stress disorder (PTSD), is fully recruited.

BTF fund manager invests in Melbourne-based company April 12, 2018

Venture capital firm Brandon Capital has announced its first investment from the government’s Biomedical Translation Fund - $7.75 million towards Global Kinetics Corporation.

RECELL trial data presented in the US April 12, 2018

AVITA Medical (ASX:AVH) has announced results from a clinical trial of the RECELL Autologous Cell Harvesting Device in the treatment of second-degree burns were presented at the American Burn Association meeting in Chicago.

Most Read

Amgen joins Digital Health CRC

Leadership of AusMedtech National Advisory Group to change

Industry welcomes first grants under BioMedTech Horizons program

Pharmaceutical leader joins QEDDI advisory committee

CSL Behring commits on World Haemophilia Day

New Stories

PharmAust enters monepantel agreement with Elanco

Applications open for new round of sector growth program

Pharmaceutical leader joins QEDDI advisory committee

Industry welcomes first grants under BioMedTech Horizons program

AusBiotech advancing collaboration in China

CSL Behring commits on World Haemophilia Day

Amgen joins Digital Health CRC

Sign In

Most Read

Amgen joins Digital Health CRC

Leadership of AusMedtech National Advisory Group to change

Industry welcomes first grants under BioMedTech Horizons program

Pharmaceutical leader joins QEDDI advisory committee

CSL Behring commits on World Haemophilia Day

Follow Us

New Stories

PharmAust enters monepantel agreement with Elanco

Applications open for new round of sector growth program

Pharmaceutical leader joins QEDDI advisory committee

Industry welcomes first grants under BioMedTech Horizons program

AusBiotech advancing collaboration in China

CSL Behring commits on World Haemophilia Day

Amgen joins Digital Health CRC